Highlights Novonesis A/S

Equities

Real-time Estimate Cboe Europe Other stock markets 04:02:33 08/05/2024 pm IST			5-day change	1st Jan Change
416.4 ^DKK	+0.52%		+8.47%	+12.13%

03/05	Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024
03/05	Novonesis Provides Sales Guidance for the Year 2024	CI

Novonesis Provides Sales Guidance for the Year 2024	03/05	CI
Final dividend	01/05	FA
Novozymes A/S Approves Dividend for the Last Four Months Ended December 31, 2023	30/04	CI
Novozymes A/S Proposes Dividend for the Last Four Months Ended December 31, 2023	08/04	CI
Novonensis expects 2024 adjusted EBITDA margin of 35%	21/03	RE
Novonesis Provides Earnings Guidance for the Year 2024	21/03	CI
Biotalys, Novonesis Sign Deal to Advance Biofungicide Candidate Development	18/03	MT
Biotalys and Novonesis Announces Manufacturing and Commercialization Partnership for EVOCA NG	18/03	CI
FMC Partners With Novonesis in Canada for Biosolution Products	12/03	MT
Novonesis to Unveil Fit-for-Food Mood-Support Probiotic at Natural Product Expo West	07/03	CI
Novo Nordisk's controlling shareholder plans to invest about $35 billion by 2030	12/02	RE
Novozymes A/S Reports Earnings Results for the Full Year Ended December 31, 2023	09/02	CI
NOVOZYMES : Q4 23: destocking noise offsets recovery in other key segments	08/02
Novozymes, Chr. Hansen Complete Merger Settlement	02/02	MT
Novozymes Completes Merger with Chr. Hansen After Securing Final Registration, Issuing B Shares	29/01	MT
Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S.	29/01	CI
Novozymes, Chr. Hansen’s Proposed Merger Secures All Regulatory Approvals	26/01	MT
Novozymes, Chr. Hansen Merger Wins Korean Regulatory Nod	20/12	MT
Celadon Pharma raises GBP2.0 million via placing	12/12	AN
Novozymes-Chr. Hansen Merger Gets EU Nod After Proposed Asset Sale	12/12	MT

No results for this search

NOVOZYMES : Q4 23: destocking noise offsets recovery in other key segments

February 08, 2024 at 07:48 pm IST